Breast Cancer Risk Assessment Models: Where We Stand and Where We Are Going(

Publisher： Nova Science Publishers, Inc.

ISSN： 1554-1134

Source： International Journal of Cancer Research and Prevention, Vol., Iss., 2017-01, pp. : 5-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Targeted Therapy for Advanced Urothelial Cancer of the Bladder: Where Do We Stand?

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 9, 2012-01 ,pp. : 1081-1087

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Targets in Triple Negative Breast Cancer - Where are we now?

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 196-209

Bentham Science Publishers

Access to resources Recommend Favorite

Intra-Arterial Therapies for Hepatocellular Carcinoma: Where Do We Stand?

By Liapi Eleni  

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1234-1246

Springer Publishing Company

Access to resources Recommend Favorite

The 2013 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: MRI in Breast Cancer: Where Are We Now?

By McLaughlin Sarah   Mittendorf Elizabeth   Bleicher Richard   McCready David   King Tari  

Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. : 28-36

Springer Publishing Company

Access to resources Recommend Favorite

Dissemination research in cancer control: where are we and where should we go?

By Bowen Deborah  

Cancer Causes and Control, Vol. 20, Iss. 4, 2009-05 ,pp. : 473-485

Springer Publishing Company

Access to resources Recommend Favorite